Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs …
S Oudard, E Banu, A Vieillefond, L Fournier… - The Journal of …, 2007 - auajournals.org
Purpose : Collecting duct carcinoma of the kidney is a rare and aggressive neoplasm of the
distal collecting tubules for which there is no established treatment. Since the histology of …
distal collecting tubules for which there is no established treatment. Since the histology of …
[PDF][PDF] Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand
F Scotté, JM Tourani, E Banu… - Journal of clinical …, 2005 - academia.edu
Purpose Onycholysis and skin toxicity occur in approximately 30% of patients treated with
docetaxel. We investigated the efficacy and safety of an Elasto-Gel (84400 APT Cedex, …
docetaxel. We investigated the efficacy and safety of an Elasto-Gel (84400 APT Cedex, …
[HTML][HTML] Multicentre randomised phase II trial of gemcitabine+ platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing …
…, C Théodore, T Nguyen, E Voog, E Banu… - European journal of …, 2015 - Elsevier
Multicentre randomised phase II trial of gemcitabine + platinum, with or without trastuzumab,
in advanced or metastatic urothelial carcinoma overexpressing Her2 - ScienceDirect Skip to …
in advanced or metastatic urothelial carcinoma overexpressing Her2 - ScienceDirect Skip to …
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT
LS Fournier, S Oudard, R Thiam, L Trinquart, E Banu… - Radiology, 2010 - pubs.rsna.org
Purpose To determine whether tumor perfusion parameters assessed by using dynamic
contrast material–enhanced computed tomography (CT) could help predict and detect response …
contrast material–enhanced computed tomography (CT) could help predict and detect response …
Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot
F Scotté, E Banu, J Medioni, E Levy, C Ebenezer… - Cancer, 2008 - Wiley Online Library
BACKGROUND Onycholysis occurs in approximately 30% of patients treated with docetaxel.
The efficacy and safety of an Elasto‐Gel frozen sock (FS) was investigated for the …
The efficacy and safety of an Elasto‐Gel frozen sock (FS) was investigated for the …
[HTML][HTML] Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
…, V Venizelos, I Xanthakis, G Xepapadakis, E Banu… - BMC cancer, 2019 - Springer
Background Hereditary cancer predisposition syndromes are responsible for approximately
5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk …
5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk …
Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy
D Helley, E Banu, A Bouziane, A Banu, F Scotte… - European urology, 2009 - Elsevier
BACKGROUND: Several studies suggest a causal relationship between platelet activation
and cancer metastasis. Activated platelet microparticles (PMPs) release vascular endothelial …
and cancer metastasis. Activated platelet microparticles (PMPs) release vascular endothelial …
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and …
…, O Rixe, B Beuselinck, C Linassier, E Banu… - Cancer immunology …, 2011 - Springer
MUC1 over-expression in renal clear-cell carcinoma (RCC) is associated with poor prognosis.
This phase II study determined the efficacy and tolerability of TG4010, a cancer vaccine …
This phase II study determined the efficacy and tolerability of TG4010, a cancer vaccine …
Multiple lung cancers prognosis: what about histology?
…, UD Ngabou, C Foucault, A Dujon, E Banu - The Annals of thoracic …, 2008 - Elsevier
BACKGROUND: Among multiple lung cancers (MLC), some may have similar histologic
classification. Demonstrating that the second tumor is a metastasis would change the stage and …
classification. Demonstrating that the second tumor is a metastasis would change the stage and …
[HTML][HTML] Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
…, L Zelek, E Sbidian, N Ortonne, E Banu… - Orphanet journal of rare …, 2013 - Springer
Background Neurofibromatosis 1 (NF1) is the most common autosomal dominant disorder,
with an incidence of 1 in 2,500-3,300 live births. NF1 is associated with significant morbidity …
with an incidence of 1 in 2,500-3,300 live births. NF1 is associated with significant morbidity …